A phase IIa study to evaluate the safety, pharmacodynamics and pharmacokinetics of TGN255 in stable haemodialysis patients

被引：0
|
作者：
Combe, Sophie
DSouza, Richard
Mysliwiec, Michal
Padmanabhan, Neal
Thomas, Mark
Villa, Giuseppe
Will, Eric
Patrick, Guy
Kennedy, Anthony
机构：
[1] Trigen, London, England
[2] Royal Devon & Exeter Hosp, Exeter Kidney Unit, Exeter EX2 5DW, Devon, England
[3] Bialystok Med Univ, Bialystok, Poland
[4] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland
[5] Birmingham Heartlands Hosp, Glaxo Renal Unit, Birmingham B9 5ST, W Midlands, England
[6] Fdn S Maugeri, Pavia, Italy
[7] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
[8] Premier Res, Crowthorne, Berks, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [31] A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout
    Steinberg, Alexandra
    Choi, Yun-Jung
    Martin, Robert
    McWherter, Charles
    Boudes, Pol
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [32] Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability
    Halton, J. M. L.
    Albisetti, M.
    Biss, B.
    Bomgaars, L.
    Brueckmann, M.
    Gropper, S.
    Harper, R.
    Huang, F.
    Luciani, M.
    Maas, H.
    Tartakovsky, I.
    Mitchell, L. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (11) : 2147 - 2157
  • [33] Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors
    William F. Maguire
    John C. Schmitz
    Jonas Scemama
    Ken Czambel
    Yan Lin
    Anthony G. Green
    Shaoyu Wu
    Huang Lin
    Shannon Puhalla
    John Rhee
    Ronald Stoller
    Hussein Tawbi
    James J. Lee
    John J. Wright
    Jan H. Beumer
    Edward Chu
    Leonard J. Appleman
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 643 - 654
  • [34] Pharmacokinetics and pharmacodynamics of lanadelumab in patients with HAE in the phase 3 HELP study
    Cicardi, M.
    Shennak, M.
    Zaragoza-Urdaz, R. H.
    Wang, Y.
    Lu, P.
    ALLERGY, 2018, 73 : 722 - 722
  • [35] A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched Controls
    Shaik, Jafar Sadik B.
    Ford, Susan L.
    Lou, Yu
    Zhang, Zhiping
    Bakshi, Kalpana K.
    Tenorio, Allan R.
    Trezza, Christine
    Spreen, William R.
    Patel, Parul
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (05): : 664 - 673
  • [36] Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: A multicenter, randomized, placebo-controlled, phase I study
    Kahan, BD
    Karlix, JL
    Ferguson, RM
    Leichtman, AB
    Mulgaonkar, S
    Gonwa, TA
    Skerjanec, A
    Schmouder, RL
    Chodoff, L
    TRANSPLANTATION, 2003, 76 (07) : 1079 - 1084
  • [37] SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE FCRN INHIBITOR UCB7665: A PHASE I STUDY
    Kiessling, P.
    Lledo-Garcia, R.
    Watanabe, S.
    Langdon, G.
    Tran, D.
    Bari, M.
    Christodoulou, L.
    Price, G.
    Smith, B.
    Byrnes, W.
    Brock, M.
    Jolles, S.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 315 - 315
  • [38] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Susanne Johansson
    David P. Rosenbaum
    Mikael Knutsson
    Maria Leonsson-Zachrisson
    Clinical and Experimental Nephrology, 2017, 21 : 407 - 416
  • [39] Phase I repeat-dose clinical study of safety, pharmacokinetics and pharmacodynamics of resveratrol
    Brown, Victoria
    Patel, Ketan
    Booth, Tristan
    Crowell, James
    Perloff, Marjorie
    Tuck, Missy
    Deyampert, Andrace
    Brown, Karen
    Gescher, Andreas
    Steward, William
    Brenner, Dean
    CANCER RESEARCH, 2008, 68 (09)
  • [40] Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study
    Cornpropst, M.
    Collis, P.
    Collier, J.
    Babu, Y. S.
    Wilson, R.
    Zhang, J.
    Fang, L.
    Zong, J.
    Sheridan, W. P.
    ALLERGY, 2016, 71 (12) : 1676 - 1683
12345